Natalie C Finch1, Sarah S Fawaz2, Chris R Neal2, Matthew J Butler2, Vivian K Lee3, Andrew J Salmon4, Abigail C Lay2, Megan Stevens5, Lusyan Dayalan2, Hamid Band6, Harry H Mellor7, Steven J Harper2, David T Shima3, Gavin I Welsh2, Rebecca R Foster2, Simon C Satchell2. 1. Bristol Renal, Bristol Medical School, University of Bristol, Bristol, United Kingdom natalie.finch@bristol.ac.uk. 2. Bristol Renal, Bristol Medical School, University of Bristol, Bristol, United Kingdom. 3. Translational Vision Research, Institute of Ophthalmology, University College London, London, United Kingdom. 4. Renal Service, Waitemata District Health Board, Auckland, New Zealand. 5. Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Exeter, United Kingdom. 6. Eppley Institute for Research in Cancer, and Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska. 7. School of Biochemistry, University of Bristol, Bristol, United Kingdom.
Abstract
BACKGROUND: Glomerular endothelial cell (GEnC) fenestrations are recognized as an essential component of the glomerular filtration barrier, yet little is known about how they are regulated and their role in disease. METHODS: We comprehensively characterized GEnC fenestral and functional renal filtration changes including measurement of glomerular K f and GFR in diabetic mice (BTBR ob-/ob- ). We also examined and compared human samples. We evaluated Eps homology domain protein-3 (EHD3) and its association with GEnC fenestrations in diabetes in disease samples and further explored its role as a potential regulator of fenestrations in an in vitro model of fenestration formation using b.End5 cells. RESULTS: Loss of GEnC fenestration density was associated with decreased filtration function in diabetic nephropathy. We identified increased diaphragmed fenestrations in diabetes, which are posited to increase resistance to filtration and further contribute to decreased GFR. We identified decreased glomerular EHD3 expression in diabetes, which was significantly correlated with decreased fenestration density. Reduced fenestrations in EHD3 knockdown b.End5 cells in vitro further suggested a mechanistic role for EHD3 in fenestration formation. CONCLUSIONS: This study demonstrates the critical role of GEnC fenestrations in renal filtration function and suggests EHD3 may be a key regulator, loss of which may contribute to declining glomerular filtration function through aberrant GEnC fenestration regulation. This points to EHD3 as a novel therapeutic target to restore filtration function in disease.
BACKGROUND: Glomerular endothelial cell (GEnC) fenestrations are recognized as an essential component of the glomerular filtration barrier, yet little is known about how they are regulated and their role in disease. METHODS: We comprehensively characterized GEnC fenestral and functional renal filtration changes including measurement of glomerular K f and GFR in diabetic mice (BTBR ob-/ob- ). We also examined and compared human samples. We evaluated Eps homology domain protein-3 (EHD3) and its association with GEnC fenestrations in diabetes in disease samples and further explored its role as a potential regulator of fenestrations in an in vitro model of fenestration formation using b.End5 cells. RESULTS: Loss of GEnC fenestration density was associated with decreased filtration function in diabetic nephropathy. We identified increased diaphragmed fenestrations in diabetes, which are posited to increase resistance to filtration and further contribute to decreased GFR. We identified decreased glomerular EHD3 expression in diabetes, which was significantly correlated with decreased fenestration density. Reduced fenestrations in EHD3 knockdown b.End5 cells in vitro further suggested a mechanistic role for EHD3 in fenestration formation. CONCLUSIONS: This study demonstrates the critical role of GEnC fenestrations in renal filtration function and suggests EHD3 may be a key regulator, loss of which may contribute to declining glomerular filtration function through aberrant GEnC fenestration regulation. This points to EHD3 as a novel therapeutic target to restore filtration function in disease.
Authors: Sebastian Oltean; Yan Qiu; Joanne K Ferguson; Megan Stevens; Chris Neal; Amy Russell; Amit Kaura; Kenton P Arkill; Kirstie Harris; Clare Symonds; Katja Lacey; Lihini Wijeyaratne; Melissa Gammons; Emma Wylie; Richard P Hulse; Chloe Alsop; George Cope; Gopinath Damodaran; Kai B Betteridge; Raina Ramnath; Simon C Satchell; Rebecca R Foster; Kurt Ballmer-Hofer; Lucy F Donaldson; Jonathan Barratt; Hans J Baelde; Steven J Harper; David O Bates; Andrew H J Salmon Journal: J Am Soc Nephrol Date: 2014-12-26 Impact factor: 10.121
Authors: E Jennifer Weil; Kevin V Lemley; Clinton C Mason; Berne Yee; Lois I Jones; Kristina Blouch; Tracy Lovato; Meghan Richardson; Bryan D Myers; Robert G Nelson Journal: Kidney Int Date: 2012-06-20 Impact factor: 10.612
Authors: Vivian K Lee; Brett M Hosking; Joanna Holeniewska; Ewa C Kubala; Peter Lundh von Leithner; Peter J Gardner; Richard H Foxton; David T Shima Journal: Diabetologia Date: 2018-08-09 Impact factor: 10.122
Authors: Megan Stevens; Christopher R Neal; Andrew H J Salmon; David O Bates; Steven J Harper; Sebastian Oltean Journal: Nephron Date: 2018-01-26 Impact factor: 2.847